Clinical Trial Update: Prospective Clinical Trial of Crisugabalin Capsules in the Treatment of Generalized Anxiety Disorder [Phase 2]

View source ↗

Summary

Prospective Phase 2 trial evaluating Crisugabalin capsules for generalized anxiety disorder, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Drugs mentioned

• Crisugabalin capsules

Snippet

Sponsor: Anhui Medical University | Conditions: Generalized Anxiety Disorder | Phase 2 | Status: RECRUITING